Cited by 88Thyroid Cancer Diagnosis and TreatmentThyroid and Parathyroid SurgeryThyroid Disorders and Treatments

Thyroid cancer in toxic and non-toxic multinodular goiter

Open access
Cerci, C, Cerci, SS, Eroglu, E, Dede, M, Kapucuoglu, N, Yildiz, M, Bulbul, M·2007·Journal of Postgraduate Medicine

Abstract

Background: Many authors have claimed that hyperthyroidism protects against thyroid cancer and believed that the incidence of malignancy is lower in patients with toxic multinodular goiter (TMG) than in those with non-toxic multinodular goiter. But in recent studies, it was reported that the incidence of malignancy with TMG is not as low as previously thought. Aim: To compare the thyroid cancer incidence in patients with toxic and non-toxic multinodular goiter. Settings and Design: Histology reports of patients treated surgically with a preoperative diagnosis of toxic and non-toxic multinodular goiter were reviewed to identify the thyroid cancer incidence. Patients having a history of neck irradiation or radioactive iodine therapy were excluded from the study. Materials and Methods: We reviewed 294 patients operated between 2001-2005 from toxic and non-toxic multinodular goiter. One hundred and twenty-four of them were toxic and 170 were non-toxic. Hyperthyroidism was diagnosed by elevated tri-iodothyroinine / thyroxine ratios and low thyroid-stimulating hormone with clinical signs and symptoms. All patients were evaluated with ultrasonography and scintigraphy and fine needle aspiration biopsy. Statistical Analysis Used: Significance of the various parameters was calculated by using ANOVA test. Results: The incidence of malignancy was 9% in the toxic and 10.58% in the non-toxic multinodular goiter group. Any significant difference in the incidence of cancer and tumor size between the two groups could not be detected. Conclusions: The incidence of malignancy in toxic multinodular goiter is not very low as thought earlier and is nearly the same in non-toxic multinodular goiter.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.4103/0022-3859.33855

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 3

  1. II. Menstrual and reproductive factors. Cancer Causes Control 1999;10:143-55.
  2. [13]Riccabona G. Thyroid cancer and endemic goiter: In : Stanbury JB, Hetzel BS, editors. Endemic goiter and endemic cretinism. Wiley Eastern Ltd: New Delhi; 1985. p. 33-5.
  3. [23]Baudin E, Travagli JP , Ropers J, Mancusi F , Bruno-Bossio G, Caillou B, et al . Microcarcinoma of the thyroid gland: The Gustave-Roussy Institute experience. Cancer 1998;83:553-9.

Cited by

Sorted by citations

Authors
Cerci, C., Cerci, S., Eroglu, E., Dede, M., Kapucuoglu, N., Yildiz, M., & Bulbul, M.
Affiliations
Süleyman Demirel Üniversitesi (TR)
Venue
Journal of Postgraduate Medicine
Published
2007
Volume
53
Issue
3
Pages
157-160
ISSN
0022-3859 (ISSN-L)
OpenAlex
W2038432064
Cited by
88
References
27
Citations by year
2026: 1 · 2025: 3 · 2024: 3 · 2023: 2 · 2022: 2 · 2021: 6 · 2020: 4 · 2019: 7 · 2018: 3 · 2017: 4 · 2016: 7 · 2015: 5 · 2014: 5 · 2013: 4 · 2012: 9
FWCI
3.41
Type
journal article
Language
en
Open access
Locations
  • Journal of Postgraduate Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • TSpace (University of Toronto) (submittedVersion)
  • Bioline International (Bioline International) (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Cancer Diagnosis and Treatment
  • Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
Keywords
thyroid cancer, toxic multinodular goiter, hyperthyroidism, thyroid cancer incidence, cancer risk, thyroid nodules, tumor size
MeSH terms
Carcinoma, Papillary, Female, Goiter, Nodular, Humans, Hyperthyroidism, Male, Retrospective Studies, Thyroid Neoplasms, Adenoma, Oxyphilic, Carcinoma, Papillary, Follicular

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review